AB

Abhishek Bhandari

Director Director DIN 10141391
DIN 10141391 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2023
Shareholding value •••• Premium profile

About Abhishek Bhandari

Data last updated:

Abhishek Bhandari was a Director at Sahviryam Health Series Private Limited (2023–2026) and Director at Sahviryam Solar Nexus Private Limited (2025–2026). The companies operate in Paper.

DIN 10141391
Primary Designation Director
Industry Paper
First Appointment 29 Apr 2023

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Apr 20232023Active
Director21 Jan 20252025Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sahviryam Health Series Private Limited
Sahviryam Solar Nexus Private Limited
Premium access

Shareholding and investment profile for Abhishek Bhandari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Bhandari

Abhishek Bhandari was first appointed on 29 Apr 2023 as Director at Sahviryam Health Series Private Limited. The most recent appointment on record is 21 Jan 2025 at Sahviryam Solar Nexus Private Limited.

Abhishek Bhandari held 2 earlier board appointments: Sahviryam Health Series Private Limited (Director, 29 Apr 2023 to 24 Jan 2026); Sahviryam Solar Nexus Private Limited (Director, 21 Jan 2025 to 22 Jan 2026).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available